LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.842
AS - Asia 11.548
EU - Europa 9.751
SA - Sud America 1.363
AF - Africa 208
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 11
Totale 47.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.552
SG - Singapore 3.556
CN - Cina 3.332
GB - Regno Unito 3.140
IT - Italia 1.587
HK - Hong Kong 1.483
BR - Brasile 1.021
DE - Germania 991
VN - Vietnam 976
SE - Svezia 964
FI - Finlandia 746
UA - Ucraina 568
TR - Turchia 531
BD - Bangladesh 491
FR - Francia 400
RU - Federazione Russa 391
PL - Polonia 370
KR - Corea 306
BG - Bulgaria 213
IN - India 206
CA - Canada 124
AR - Argentina 122
MX - Messico 95
IQ - Iraq 87
JP - Giappone 79
NL - Olanda 79
ID - Indonesia 78
ZA - Sudafrica 52
PK - Pakistan 51
ES - Italia 47
VE - Venezuela 47
AE - Emirati Arabi Uniti 45
EC - Ecuador 43
MY - Malesia 39
BE - Belgio 35
CO - Colombia 33
PH - Filippine 33
MA - Marocco 32
UZ - Uzbekistan 32
AT - Austria 30
CL - Cile 29
TW - Taiwan 29
LT - Lituania 26
SA - Arabia Saudita 25
EG - Egitto 24
IE - Irlanda 24
JO - Giordania 23
PY - Paraguay 23
CZ - Repubblica Ceca 22
GR - Grecia 20
RO - Romania 18
AU - Australia 17
BO - Bolivia 16
NP - Nepal 16
PE - Perù 16
CR - Costa Rica 15
DZ - Algeria 15
IR - Iran 15
TH - Thailandia 15
AZ - Azerbaigian 14
KE - Kenya 14
ET - Etiopia 13
OM - Oman 13
JM - Giamaica 12
TN - Tunisia 12
CH - Svizzera 11
IL - Israele 11
NG - Nigeria 10
UY - Uruguay 10
AL - Albania 9
BY - Bielorussia 9
DO - Repubblica Dominicana 9
HN - Honduras 9
KZ - Kazakistan 9
SI - Slovenia 9
NI - Nicaragua 8
RS - Serbia 8
EU - Europa 7
NZ - Nuova Zelanda 7
GE - Georgia 6
LB - Libano 6
PA - Panama 6
SC - Seychelles 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
HU - Ungheria 5
QA - Qatar 5
UG - Uganda 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
CY - Cipro 4
KG - Kirghizistan 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
GT - Guatemala 3
HR - Croazia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
Totale 47.692
Salva come PNG Salva come JPEG
Città #
Singapore 2.428
Fairfield 2.192
Ashburn 2.105
Santa Clara 2.051
Southend 2.017
Woodbridge 1.602
Hong Kong 1.468
Houston 1.299
Jacksonville 1.230
Chandler 1.197
Hefei 1.151
San Jose 942
Seattle 845
Wilmington 803
Dearborn 796
Ann Arbor 776
Cambridge 721
Beijing 605
Chicago 581
Nyköping 546
London 521
Helsinki 508
Los Angeles 485
Warsaw 358
Ho Chi Minh City 309
Modena 307
The Dalles 307
New York 295
Seoul 289
Izmir 285
Council Bluffs 266
San Diego 237
Hanoi 234
Princeton 221
Sofia 207
Salt Lake City 206
Eugene 201
Des Moines 169
Lauterbourg 167
Milan 159
Munich 139
Buffalo 138
Tampa 131
Shanghai 130
Moscow 124
Dallas 119
Grafing 101
São Paulo 98
Elk Grove Village 95
Columbus 91
Rome 90
Falls Church 86
Orem 79
Bremen 58
Sterling 57
Guangzhou 53
Tokyo 53
Phoenix 52
Kunming 48
Boardman 47
Da Nang 47
Frankfurt am Main 45
Istanbul 44
Jakarta 43
Baghdad 41
Lancaster 39
Redwood City 39
Rio de Janeiro 38
Turku 38
Haiphong 37
Montreal 36
Bologna 35
Miami 35
Norwalk 35
Mexico City 34
San Mateo 34
Brooklyn 33
Detroit 33
Fremont 32
Atlanta 31
Kent 31
Manchester 31
Amsterdam 30
Toronto 30
Brussels 29
Chennai 29
San Francisco 28
Denver 27
Naples 27
Dulles 26
Bari 25
Falkenstein 25
Tashkent 25
Johannesburg 24
Biên Hòa 23
Kilburn 23
Miano 23
Verona 23
Poplar 22
Washington 22
Totale 34.147
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 709
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 451
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 440
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 430
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 425
Gender, fatty liver and GGT 419
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 419
Review article: diabetes, genetics and ethnicity 412
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 406
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 395
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 386
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 370
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 364
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 364
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 360
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 355
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 351
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 349
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 342
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 340
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 338
Endocrine and liver interaction: the role of endocrine pathways in NASH 338
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 327
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 324
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 323
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 322
Nonalcoholic fatty liver disease and aging: epidemiology to management 319
Statins in liver disease: a molehill, an iceberg, or neither? 317
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 317
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 314
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 314
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 309
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 309
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 307
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 307
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 306
If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? 299
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 298
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 294
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 292
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 292
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 291
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 290
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 288
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 288
From NAFLD in clinical practice to answers from guidelines. 287
Advances in the comprehension of the pathophysiology of bile secretion 286
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 285
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 284
Chicken or egg turned into head or belly 282
Effects of acute changes of bile acid pool composition on biliary lipid secretion 282
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 282
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 280
Diet and gallstones in Italy: the cross-sectional MICOL results. 279
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 277
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 277
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 276
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 275
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 274
Apolipoprotein synthesis in nonalcoholic steatohepatitis 273
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 271
Anatomia e fisiologia delle vie biliari 270
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 270
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 269
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 269
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 268
Bile acid structure and regulation of biliary protein secretion and composition in man 267
Cardiovascular and systemic risk in nonalcoholic fatty liver disease -Atherosclerosis as a major player in the natural course of NAFLD 267
Review article: hepatic steatosis and insulin resistance 264
Effect of ursocholic acid on bile lipid secretion and composition 263
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 261
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 260
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 259
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 258
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 257
Hepatitis C and diabetes: the inevitable coincidence? 255
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 252
Risk factors for hospital readmission of elderly patients 251
Nonalcoholic fatty liver disease induced by leuprorelin acetate 251
Growth hormone plasma levels in nonalcoholic fatty liver disease 249
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 247
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 247
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 245
Influence of age and sex on serum concentrations of total dimeric activin A 244
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 244
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 244
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 243
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 243
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 241
Heart failure and chronic kidney disease in a registry of internal medicine wards 241
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 238
Bile acid composition and hepatic sterol metabolism in man. The effect of deoxycholic acid administration. 237
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 237
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 236
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 236
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 235
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 235
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 233
Metabolic alterations and chronic hepatitis C: treatment strategies. 231
α1-antitrypsin mutations in NAFLD: High prevalence and association with altered iron metabolism but not with liver damage 230
Totale 30.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 0 0 0 0 0 0 0 146
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20242.003 84 119 114 136 457 221 216 286 56 42 75 197
2024/20257.463 263 87 129 495 1.607 971 588 413 707 257 838 1.108
2025/202616.022 897 613 1.224 1.896 2.968 1.580 1.933 628 1.369 1.138 992 784
Totale 47.902